Table 1.
Baseline characteristics of patients
| Variable | RAT-AVR group | TAVI group | p-value |
|---|---|---|---|
| No. of patients | 10 | 20 | |
| Age (yr) | 84.0 (81.8–87.0) | 83.0 (81.3–85.8) | 0.54 |
| Female sex | 5 (50.0) | 10 (50.0) | >0.99 |
| Body surface area (m2) | 1.59 (1.37–1.72) | 1.55 (1.35–1.67) | 0.57 |
| Hypertension | 5 (50.0) | 14 (70.0) | 0.43 |
| Diabetes mellitus | 0 (0) | 6 (30.0) | 0.07 |
| COPD | 2 (20.0) | 0 (0) | 0.10 |
| Chronic kidney disease | 0 (0) | 5 (25.0) | >0.99 |
| Coronary artery disease | 4 (40.0) | 4 (20.0) | >0.99 |
| Cardiac rhythm | |||
| Sinus rhythm | 9 (90.0) | 17 (85 .0) | 0.53 |
| Atrial fibrillation | 1 (10.0) | 3 (15.0) | 0.53 |
| STS scorea) | 3.33 (2.44–5.97) | 3.94 (2.28–5.90) | 0.79 |
| Low | 6 (60.0) | 11 (55.0) | |
| Intermediate | 4 (40.0) | 6 (30.0) | |
| High | 0 (0) | 3 (15.0) |
Values are presented as number only, median (interquartile range), or number (%).
RAT-AVR, right anterior mini-thoracotomy aortic valve replacement; TAVI, transcatheter aortic valve implantation; COPD, chronic obstruction pulmonary disease; STS, Society of Thoracic Surgeons.
a)
Low risk, STS score <4%; intermediate risk, STS score 4%–8%; or high risk, STS score >8%.